Valuation: Alpa Laboratories Limited

Market Cap 978M 10.27M 8.98M 8.25M 7.69M 14.58M 14.8M 99.02M 38.49M 481M 38.54M 37.71M 1.66B P/E 2024
10.4x
P/E 2025 11.2x
Enterprise Value -149M -1.57M -1.37M -1.26M -1.17M -2.23M -2.26M -15.12M -5.88M -73.39M -5.89M -5.76M -253M EV / Sales 2024
0.81x
EV / Sales 2025 0.94x
Free-Float
42.71%
Yield 2024 *
-
Yield 2025 -
05-29 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
04-11 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
02-25 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
02-11 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-07-31 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
25-05-28 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-02-14 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
25-02-13 Alpa Laboratories Limited Appoints Srashti Chopra as Company Secretary and Compliance Officer CI
25-02-13 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2024 CI
24-11-14 Alpa Laboratories Limited Announces Resignation of Swati Bagh as Company Secretary and Compliance Officer, Effective December 10, 2024 CI
24-08-31 Alpa Laboratories Limited Appoints Pratik Shah as an Additional Director CI
24-08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
1 day-0.54%
1 week+0.32%
Current month+1.73%
1 month-0.17%
3 months+32.79%
6 months-11.94%
Current year-11.55%
1 week 67.26
Extreme 67.26
70
1 month 66.61
Extreme 66.61
73.69
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
105.9
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 2016-05-27
Director of Finance/CFO 65 -
Compliance Officer - 2026-04-10
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 1966-12-31
Director/Board Member - 2016-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+0.32%-32.86%-2.46% 15.19M
+1.81%+2.25%+13.63%+81.62% 48B
-2.54%+3.72%+66.86%+116.52% 36.89B
+0.15%+1.26%-3.64%+44.11% 12.37B
+3.71%+3.56%+13.95%+98.68% 11.95B
+0.39%+0.58%+32.90%+120.94% 9.01B
+0.66%-0.57%+19.74%+46.69% 7.2B
+0.71%+1.75%+52.67%-6.28% 7.05B
+9.99%+32.94%-15.50%+25.64% 6.58B
+0.68%+2.63%+20.79%+240.34% 6.55B
Average +1.50%+3.85%+16.86%+76.58% 14.56B
Weighted average by Cap. +0.84%+3.35%+28.06%+89.73%

Financials

2024 2025
Net sales 1.09B 11.42M 9.98M 9.18M 8.55M 16.22M 16.47M 110M 42.82M 535M 42.87M 41.95M 1.84B 1.12B 11.81M 10.32M 9.49M 8.84M 16.78M 17.03M 114M 44.28M 553M 44.33M 43.38M 1.9B
Net income 168M 1.76M 1.54M 1.42M 1.32M 2.5M 2.54M 16.99M 6.61M 82.47M 6.61M 6.47M 284M 195M 2.05M 1.79M 1.65M 1.53M 2.91M 2.95M 19.76M 7.68M 95.87M 7.69M 7.52M 330M
Net Debt -876M -9.2M -8.04M -7.39M -6.89M -13.07M -13.27M -88.74M -34.5M -431M -34.54M -33.8M -1.48B -1.13B -11.83M -10.35M -9.51M -8.86M -16.81M -17.06M -114M -44.37M -554M -44.42M -43.47M -1.91B
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
453
Date Price Change Volume
26-07-03 ₹68.72 -0.54% 5,100
26-07-02 ₹69.09 +0.29% 6,161
26-07-01 ₹68.89 +1.98% 20,282
26-06-30 ₹67.55 -0.69% 6,085
26-06-29 ₹68.02 -0.70% 8,920
  1. Stock Market
  2. Stocks
  3. ALPA Stock